Moreno A - Search Results

1

From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis.

Lincecum JM, Vieira FG, Wang MZ, Thompson K, De Zutter GS, Kidd J, Moreno A, Sanchez R, Carrion IJ, Levine BA, Al-Nakhala BM, Sullivan SM, Gill A, Perrin S. Lincecum JM, et al. Among authors: moreno a. Nat Genet. 2010 May;42(5):392-9. doi: 10.1038/ng.557. Epub 2010 Mar 28. Nat Genet. 2010. PMID: 20348957

2

C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS.

Hatzipetros T, Bogdanik LP, Tassinari VR, Kidd JD, Moreno AJ, Davis C, Osborne M, Austin A, Vieira FG, Lutz C, Perrin S. Hatzipetros T, et al. Among authors: moreno aj. Brain Res. 2014 Oct 10;1584:59-72. doi: 10.1016/j.brainres.2013.10.013. Epub 2013 Oct 18. Brain Res. 2014. PMID: 24141148

3

Dexpramipexole is ineffective in two models of ALS related neurodegeneration.

Vieira FG, LaDow E, Moreno A, Kidd JD, Levine B, Thompson K, Gill A, Finkbeiner S, Perrin S. Vieira FG, et al. Among authors: moreno a. PLoS One. 2014 Dec 19;9(12):e91608. doi: 10.1371/journal.pone.0091608. eCollection 2014. PLoS One. 2014. PMID: 25526593 Free PMC article.

4

Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS.

Vieira FG, Ping Q, Moreno AJ, Kidd JD, Thompson K, Jiang B, Lincecum JM, Wang MZ, De Zutter GS, Tassinari VR, Levine B, Hatzipetros T, Gill A, Perrin S. Vieira FG, et al. Among authors: moreno aj. PLoS One. 2015 Aug 19;10(8):e0135570. doi: 10.1371/journal.pone.0135570. eCollection 2015. PLoS One. 2015. PMID: 26288094 Free PMC article.

5

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS.

Hatzipetros T, Kidd JD, Moreno AJ, Thompson K, Gill A, Vieira FG. Hatzipetros T, et al. Among authors: moreno aj. J Vis Exp. 2015 Oct 6;(104):53257. doi: 10.3791/53257. J Vis Exp. 2015. PMID: 26485052 Free PMC article.

6

CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits.

Vieira FG, Hatzipetros T, Thompson K, Moreno AJ, Kidd JD, Tassinari VR, Levine B, Perrin S, Gill A. Vieira FG, et al. Among authors: moreno aj. IBRO Rep. 2017 Mar 12;2:47-53. doi: 10.1016/j.ibror.2017.03.001. eCollection 2017 Jun. IBRO Rep. 2017. PMID: 30135932 Free PMC article.

7

SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS.

Gill C, Phelan JP, Hatzipetros T, Kidd JD, Tassinari VR, Levine B, Wang MZ, Moreno A, Thompson K, Maier M, Grimm J, Gill A, Vieira FG. Gill C, et al. Among authors: moreno a. Sci Rep. 2019 Apr 30;9(1):6724. doi: 10.1038/s41598-019-43164-z. Sci Rep. 2019. PMID: 31040321 Free PMC article.

8

PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS.

Vieira FG, Tassinari VR, Kidd JD, Moreno A, Thompson K, Perrin S, Gill A, Hatzipetros T. Vieira FG, et al. Among authors: moreno a. PLoS One. 2024 Feb 15;19(2):e0292190. doi: 10.1371/journal.pone.0292190. eCollection 2024. PLoS One. 2024. PMID: 38359044 Free PMC article.

9

Antibacterial Activity of Epigallocatechin-3-gallate (EGCG) Loaded Lipid-chitosan Hybrid Nanoparticle against Planktonic Microorganisms.

Moreno APD, Marcato PD, Silva LB, Salvador SLS, Arco MCGD, Moraes JCB, Silva RSD, Rossi A. Moreno APD, et al. J Oleo Sci. 2024;73(5):709-716. doi: 10.5650/jos.ess23155. J Oleo Sci. 2024. PMID: 38692893 Free article.

10

Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model.

Watson E EE, Hueniken K, Lee J, Huang SH, El Maghrabi A, Xu W, Moreno AC, Tsai CJ, Hahn E, McPartlin AJ, Yao CMKL, Goldstein DP, De Almeida JR, Waldon JN, Fuller CD, Hope AJ, Ruggiero SL, Glogauer M, Hosni AA. Watson E EE, et al. Among authors: moreno ac. J Clin Oncol. 2024 May 1:JCO2301951. doi: 10.1200/JCO.23.01951. Online ahead of print. J Clin Oncol. 2024. PMID: 38691822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,457 results

Search Page